UK stocks set for weekly gains as investors seek shelter in defensive sectors

By Reuters News

- Britain's main stock indexes were heading for weekly gains on Friday, as investors sought refuge in defensive sectors from a rout in AI-linked equities globally, while a dip in bond yields boosted risk sentiment ahead of next week's inflation figures.

The blue-chip FTSE 100 index .FTSE edged 0.08% lower to 10,831.70 points by 10:12 GMT, but was on track for its best week since early April, while the midcap FTSE 250 .FTMC rose 0.55%.

  • The defensive healthcare sector was set for a nearly 5% gain for the week, despite falling over 1% on Friday

  • Drugmakers AstraZeneca AZN.L and GSK GSK.L fell 1.8% and 1%, respectively, on the day

  • The personal goods sector .FTNMX402040 was up 7.2% for the week

  • Heavily weighted banks slipped on Friday after the Guardian reported British finance minister John Healey was set to tax the lenders in the budget later this month

  • "While big international banks in the UK are likely to be less affected, domestic names are in the firing line," said Kathleen Brooks, research director at XTB, in a note

  • NatWest Group NWG.L and Lloyds Banking LLOY.L were down 2.2% each

  • Bank of England Governor Andrew Bailey said signs of second-round inflation were limited ahead of next week's data release for September

  • Traders are pricing in four BoE rate hikes over the next 12 months, according to LSEG data

  • The UK's 10-year benchmark yields were heading for weekly declines after three straight weeks of gains

  • Defence stocks .FTNMX502010 helped limit the losses on Friday: BAE Systems BAES.L, Melrose Industries MRON.L and Babcock International BAB.L rose between 1.5% and 3.7%

  • E-commerce group THG THG.L rose 6.7%, extending a surge of 16% on Thursday after it raised its annual adjusted core profit forecast

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk